Nordwand Advisors, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Nordwand Advisors, LLC
- $229 Billion
- Q2 2024
A detailed history of Nordwand Advisors, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordwand Advisors, LLC holds 4,000 shares of LXRX stock, worth $6,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$6,280
Previous $9.6 Million
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
131Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$275 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$15.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$13 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$12 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$9.18 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $296M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...